Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1

4(57.1%)

N/A

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 1(4)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06507111Not ApplicableCompleted

The Impact of Probiotics on Well-being in Women

Role: collaborator

NCT05355571Not ApplicableCompleted

The Impact of Probiotic Supplementation on Antibiotic Induced Changes in Gastrointestinal Function And/or Faecal Microbiota Composition

Role: collaborator

NCT05009680Phase 1Unknown

A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Role: collaborator

NCT04077671Phase 1Completed

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

Role: collaborator

NCT02935192Phase 3Completed

Phase 3 Trial of Serbian Seasonal Influenza Vaccine

Role: collaborator

NCT02585700Phase 1Completed

A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

Role: collaborator

NCT02141763Phase 1Completed

Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis

Role: collaborator

All 7 trials loaded